TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
VSTM
Verastem
$
()
VSTM
Verastem reports Q4 adjusted EPS ($1.10), consensus (62c)
VSTM
3/14/2024 - 16:26pm
Verastem receives Orphan Drug Designation from FDA for avutometinib
VSTM
3/5/2024 - 17:29pm
Verastem treatment of low grade serous ovarian cancer granted orphan designation
VSTM
3/5/2024 - 08:53am
Verastem granted fast track designation for Avutometinib+Sotorasib in NSCLC
VSTM
1/18/2024 - 16:02pm
B. Riley sees these two biotech stocks outperforming in 2024
ALLO
,
VSTM
,
XBI
12/27/2023 - 07:58am
Verastem selects GFH375/VS-7375 as lead program of pact with GenFleet
VSTM
12/18/2023 - 07:11am
Verastem initiates RAMP 301 trial
VSTM
12/13/2023 - 07:27am
Verastem assumed with a Buy at BTIG
VSTM
11/21/2023 - 06:00am
Verastem price target lowered to $34 from $39 at Truist
VSTM
11/15/2023 - 07:11am
Verastem files $300M mixed securities shelf
VSTM
11/8/2023 - 17:03pm
Verastem reports Q3 adjusted EPS (71c), consensus (84c)
VSTM
11/8/2023 - 16:19pm
Verastem announces results from avutometinib, defactinib trial at IGCS 2023
VSTM
11/6/2023 - 07:06am
Verastem announces initial results of RAMP 203 trial of avutometinib, LUMAKRAS
VSTM
10/15/2023 - 06:45am
Verastem presents avutometinib and defactinib combination program updates
VSTM
9/28/2023 - 14:17pm
Verastem initiated with a Buy at B. Riley
VSTM
9/26/2023 - 20:46pm
dynamic_feed
Breaking News
search
Search
menu
Menu